Forbes
In an article for Forbes, Senior Lecturer Guadalupe Hayes-Mota '08 MS '16, MBA '16 explores how “AI is now embedded in the critical path of drug discovery, and it is making consequential decisions at a speed and scale that existing governance structures were simply not designed to handle.” Hayes-Mota emphasizes: “The goal is to ensure that as AI accelerates the machine of drug development, we have deliberate mechanisms for human accountability threaded through every critical junction.”